28 results on '"Guo, S."'
Search Results
2. PND51 Trends and Characteristics in Opioid Analgesic Use for Migraine in US Emergency Departments: Analysis of National Hospital Ambulatory Medical Care Survey 2007-2018 Data
3. PCR153 Factors Associated with Glucose-Lowering Drug Adherence Among U.S. Adults with Type 2 Diabetes
4. PDG82 Machine Learning to Identify Diabetes Patients with Canagliflozin Prescriptions at High-Risk of Lower Extremity Amputation Using Real-Word DATA
5. Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)
6. Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation
7. Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland
8. Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland
9. PSY55 - Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)
10. Budget Impact Analysis Of Using Amyloid Positron Emission Tomography (Pet) In The Diagnosis Of Alzheimer’s Disease (Ad) In The United States
11. Predicting the long-term clinical effectiveness of daclizumab in relapsing-remitting multiple sclerosis: A new modeling framework using discrete event simulation
12. PND55 Multiple Sclerosis Impact Scale (MSIS-29): Its Validity and Responsiveness in Clinical Trial-Based Subjects
13. PMH26 Modeling Economic Consequences of Cardiometabolic Changes with Lurasidone Versus Other Atypical Antipsychotics in Schizophrenia
14. PMH38 ECONOMIC IMPLICATIONS OF THE EFFECT OF LURASIDONE VERSUS OTHER SELECTED ATYPICAL ANTIPSYCHOTICS ON CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH SCHIZOPHRENIA
15. PND16 MODELING THE CLINICAL AND ECONOMIC IMPLICATIONS OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE IN GERMANY
16. PCV87 PERSISTENCE WITH AMIODARONE OR SOTALOL AND ITS IMPACT ON A TRIAL FIBRILLATION-RELATED HOSPITALIZATIONS AND CARDIOVERSIONS
17. PND12 MODELING THE CLINICAL AND ECONOMIC CONSEQUENCES OF TREATING RELAPSING FORM OF MULTIPLE SCLEROSIS WITH SUBCUTANEOUS VERSUS INTRAMUSCULAR INTERFERON-BETA-IA
18. ND3 MODELING TREATING MULTIPLE SCLEROSISWITH DISEASE MODIFYING DRUGS USING DISCRETE EVENT SIMULATION
19. PND11 - Budget Impact Analysis Of Using Amyloid Positron Emission Tomography (Pet) In The Diagnosis Of Alzheimer’s Disease (Ad) In The United States
20. PND10 - Predicting the long-term clinical effectiveness of daclizumab in relapsing-remitting multiple sclerosis: A new modeling framework using discrete event simulation
21. PND43 - Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland
22. PRM100 - Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation
23. PND45 - Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland
24. PND11 Budget Impact Analysis Of Using Amyloid Positron Emission Tomography (Pet) In The Diagnosis Of Alzheimer’s Disease (Ad) In The United States
25. PND45 Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland
26. PND43 Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland
27. PRM100 Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation
28. PND10 Predicting the long-term clinical effectiveness of daclizumab in relapsing-remitting multiple sclerosis: A new modeling framework using discrete event simulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.